Abstract
The development of an Aptamer based biosensor for the selective detection of human epidermal growth factor receptor 2 (HER2) with high sensitivity and specificity was achieved. A screen-printed carbon electrode was used in the scope of this work. The HER2 Aptamer was immobilized via electrostatic adsorption on the surface of a screen-printed electrode, which was modified with Au Nanoparticles (~ 20 nm diameter) to support the Aptamer immobilization. The Aptasensor was extensively investigated using Cyclic voltammetry, Differential pulse voltammetry, Electrochemical impedance spectroscopy, Fourier transform infrared spectroscopy and Atomic force microscopy. The Aptasensor exhibits a fast response with a binding time of only 5 min and shows a log-linear response over a wide concentration range of 0.001—100 ng/mL. Moreover, it has high sensitivity and enhanced detection limit reaching 52.85 μA/ng/mL, and 0.001 ng/mL, respectively, with a relative standard deviation < 5%. The Aptasensor selectivity was studied by using different interfering substances, and the results demonstrate that the Aptasensor is efficient for the detection of HER2 with approximately 8% extent of the interference.
Similar content being viewed by others
References
S.A.A. Ahmad, M.S. Zaini, M.A. Kamarudin, An electrochemical sandwich immunosensor for the detection of HER2 using antibody-conjugated PbS quantum dot as a label. J Pharm Biomed Anal 174, 608–617 (2019)
F. Aghaei, S.M. Seifati, N. Nasirizadeh, Development of a DNA biosensor for the detection of phenylketonuria based on a screen-printed gold electrode and hematoxylin. Anal Methods 9, 966–973 (2017)
D. Antuña-Jiménez, M.B. González-García, D. Hernández-Santos, P. Fanjul-Bolado, Screen-Printed Electrodes Modified with Metal Nanoparticles for Small Molecule Sensing. Biosensors 10, 9 (2020)
E. Arkan, R. Saber, Z. Karimi, M. Shamsipur, A novel antibody–antigen based impedimetric immunosensor for low level detection of HER2 in serum samples of breast cancer patients via modification of a gold nanoparticles decorated multiwall carbon nanotube-ionic liquid electrode. Anal Chim Acta 874, 66–74 (2015)
S.K. Arya, P. Zhurauski, P. Jolly et al., Capacitive aptasensor based on interdigitated electrode for breast cancer detection in undiluted human serum. Biosens Bioelectron 102, 106–112 (2018)
H. Beitollahi, S.Z. Mohammadi, M. Safaei, S. Tajik, Applications of electrochemical sensors and biosensors based on modified screen-printed electrodes: a review. Anal Methods 12, 1547–1560 (2020)
F. Boureau, A. Leizorovicz , F. Caulin, [The placebo effect in bone metastatic pain]. Press médicale (Paris, Fr 1983) 17, 1063–1066 (1988). https://doi.org/10.1038/nature01423.Published
G. Bezerra, C. Córdula, D. Campos et al., Electrochemical aptasensor for the detection of HER2 in human serum to assist in the diagnosis of early stage breast cancer. Anal Bioanal Chem 411, 6667–6676 (2019)
W.P. Carney, R. Neumann, A. Lipton et al., Potential clinical utility of serum HER-2/neu oncoprotein concentrations in patients with breast cancer. Clin Chem 49, 1579–1598 (2003)
L. Chun, S.-E. Kim, M. Cho et al., Electrochemical detection of HER2 using single stranded DNA aptamer modified gold nanoparticles electrode. Sensors Actuators B Chem 186, 446–450 (2013)
M. Emami, M. Shamsipur, R. Saber, R. Irajirad, An electrochemical immunosensor for detection of a breast cancer biomarker based on antiHER2–iron oxide nanoparticle bioconjugates. Analyst 139, 2858–2866 (2014)
D. Furrer, F. Sanschagrin, S. Jacob, C. Diorio, Advantages and disadvantages of technologies for HER2 testing in breast cancer specimens. Am J Clin Pathol 144, 686–703 (2015)
M. Freitas, H.P.A. Nouws, C. Delerue-Matos, Electrochemical sensing platforms for HER2-ECD breast cancer biomarker detection. Electroanalysis 31, 121–128 (2019)
M. Freitas, M.M.P.S. Neves, H.P.A. Nouws, C. Delerue-Matos, Quantum dots as nanolabels for breast cancer biomarker HER2-ECD analysis in human serum. Talanta 208, 120430 (2020a)
M. Freitas, H.P.A. Nouws, E. Keating et al., Immunomagnetic bead-based bioassay for the voltammetric analysis of the breast cancer biomarker HER2-ECD and tumour cells using quantum dots as detection labels. Microchim Acta 187, 1–10 (2020b)
W.J. Gullick, Alternative strategies for targeting the epidermal growth factor system in cancer. Breast Cancer Res 3, 390–394 (2001). https://doi.org/10.1186/bcr328
M. Hasanzadeh, N. Shadjou, M. de la Guardia, Early stage screening of breast cancer using electrochemical biomarker detection. TrAC Trends Anal Chem 91, 67–76 (2017)
Y.W. Hartati, L.K. Letelay, S. Gaffar, et al., Cerium oxide-monoclonal antibody bioconjugate for electrochemical immunosensing of HER2 as a breast cancer biomarker. Sens Bio-Sensing Res 27, 100316 (2020)
W.J. Köstler, B. Schwab, C.F. Singer et al., Monitoring of serum Her-2/neu predicts response and progression-free survival to trastuzumab-based treatment in patients with metastatic breast cancer. Clin Cancer Res 10, 1618–1624 (2004)
R. Khan, M. Pal, A.V. Kuzikov et al., Impedimetric immunosensor for detection of cardiovascular disorder risk biomarker. Mater Sci Eng C 68, 52–58 (2016)
R. Laocharoensuk, Development of Electrochemical Immunosensors towards Point-of-care Cancer Diagnostics: Clinically Relevant Studies. Electroanalysis 28, 1716–1729 (2016)
V. Ludovini, S. Gori, M. Colozza et al., Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival. Ann Oncol 19, 883–890 (2008)
O.K. Mahfoud, T.Y. Rakovich, A. Prina-Mello et al., Detection of ErbB2: nanotechnological solutions for clinical diagnostics. RSC Adv 4, 3422–3442 (2014)
S. Mehennaoui, S. Poorahong, G.C. Jimenez, M. Siaj, Selection of high affinity aptamer-ligand for dexamethasone and its electrochemical biosensor. Sci Rep 9, 6600 (2019). https://doi.org/10.1038/s41598-019-42671-3
S. Mittal, H. Kaur, N. Gautam, A.K. Mantha, Biosensors for breast cancer diagnosis: A review of bioreceptors, biotransducers and signal amplification strategies. Biosens Bioelectron 88, 217–231 (2017)
A. Mishra, M. Verma, Cancer biomarkers: are we ready for the prime time? Cancers (basel) 2, 190–208 (2010)
J. Mohanraj, D. Durgalakshmi, A. Rakkesh, Current Trends in Disposable Graphene-Based Printed Electrode for Electrochemical Biosensors. J Electrochem Soc 167, 67523 (2020)
M.A.H. Nawaz, S. Rauf, G. Catanante et al., One step assembly of thin films of carbon nanotubes on screen printed interface for electrochemical aptasensing of breast cancer biomarker. Sensors 16, 1651 (2016)
J.H. Niazi, S.K. Verma, S. Niazi, A. Qureshi, In vitro HER2 protein-induced affinity dissociation of carbon nanotube-wrapped anti-HER2 aptamers for HER2 protein detection. Analyst 140, 243–249 (2015)
D. Ou, D. Sun, X. Lin et al., A dual-aptamer-based biosensor for specific detection of breast cancer biomarker HER2 via flower-like nanozymes and DNA nanostructures. J Mater Chem B 7, 3661–3669 (2019)
S. Patris, P. De Pauw, M. Vandeput et al., Nanoimmunoassay onto a screen printed electrode for HER2 breast cancer biomarker determination. Talanta 130, 164–170 (2014)
A. Qureshi, Y. Gurbuz, J.H. Niazi, Label-free capacitance based aptasensor platform for the detection of HER2/ErbB2 cancer biomarker in serum. Sensors Actuators B Chem 220, 1145–1151 (2015)
A. Ravalli, D. Voccia, I. Palchetti, G. Marrazza, Electrochemical, electrochemiluminescence, and photoelectrochemical aptamer-based nanostructured sensors for biomarker analysis. Biosensors 6, 39 (2016)
G. Riccio, G. Esposito, E. Leoncini et al. Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents. FASEB J 23(9), 3171–3178 (2009). https://doi.org/10.1096/fj.09-131383
P.F. Rostamabadi, E. Heydari-Bafrooei, Impedimetric aptasensing of the breast cancer biomarker HER2 using a glassy carbon electrode modified with gold nanoparticles in a composite consisting of electrochemically reduced graphene oxide and single-walled carbon nanotubes. Microchim Acta 186, 495 (2019)
R. Salahandish, A. Ghaffarinejad, S.M. Naghib et al., Nano-biosensor for highly sensitive detection of HER2 positive breast cancer. Biosens Bioelectron 117, 104–111 (2018)
J. Shi, J.C. Claussen, E.S. McLamore, et al., A comparative study of enzyme immobilization strategies for multi-walled carbon nanotube glucose biosensors. Nanotechnology 22, 355502 (2011)
A. Smart, A. Crew, R. Pemberton, et al., Screen-Printed Carbon Based Biosensors and their Applications in Agri-Food Safety. TrAC Trends Anal Chem 115898 (2020)
H. Sun, Y. Zu, Aptamers and their applications in nanomedicine. Small 11, 2352–2364 (2015)
A. Tabasi, A. Noorbakhsh, E. Sharifi, Reduced graphene oxide-chitosan-aptamer interface as new platform for ultrasensitive detection of human epidermal growth factor receptor 2. Biosens Bioelectron 95, 117–123 (2017)
S.D. Tallapragada, K. Layek, R. Mukherjee et al., Development of screen-printed electrode based immunosensor for the detection of HER2 antigen in human serum samples. Bioelectrochemistry 118, 25–30 (2017)
M. Tak, V. Gupta, M. Tomar, An electrochemical DNA biosensor based on Ni doped ZnO thin film for meningitis detection. J Electroanal Chem 792, 8–14 (2017). https://doi.org/10.1016/j.jelechem.2017.03.032
C. Tse, D. Brault, J. Gligorov et al., Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast cancer pa. Clin Chem 51, 1093–1101 (2005)
Q. Wang, F. Gao, J. Ni et al., Facile construction of a highly sensitive DNA biosensor by in-situ assembly of electro-active tags on hairpin-structured probe fragment. Sci Rep 6, 1–10 (2016). https://doi.org/10.1038/srep22441
Y. Zhu, P. Chandra, Y.B. Shim, Ultrasensitive and selective electrochemical diagnosis of breast cancer based on a hydrazine-Au nanoparticle-aptamer bioconjugate. Anal Chem 85, 1058–1064 (2013). https://doi.org/10.1021/ac302923k
Acknowledgements
This research was fully supported by the Royal Hashemite Courte under the Royal initiative for innovative projects in Nanotechnology.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Harahsheh, T., Makableh, Y.F., Rawashdeh, I. et al. Enhanced aptasensor performance for targeted HER2 breast cancer detection by using screen-printed electrodes modified with Au nanoparticles. Biomed Microdevices 23, 46 (2021). https://doi.org/10.1007/s10544-021-00586-9
Accepted:
Published:
DOI: https://doi.org/10.1007/s10544-021-00586-9